학술논문
Trebananib (AMG 386) in combination with sunitinib in patients with metastatic renal cell cancer: An open-label, multicenter, phase II study
Document Type
Article
Author
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 20 October 2015, 33(30):3431-3438)
Subject
Language
English
ISSN
15277755
0732183X
0732183X